- Home
- AXGN vs BALY Comparison
AXGN vs BALY Comparison
Compare AXGN & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- BALY
- Stock Information
- Founded
- AXGN N/A
- BALY 2004
- Country
- AXGN United States
- BALY United States
- Employees
- AXGN N/A
- BALY 10000
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BALY Hotels/Resorts
- Sector
- AXGN Health Care
- BALY Consumer Discretionary
- Exchange
- AXGN Nasdaq
- BALY Nasdaq
- Market Cap
- AXGN 577.0M
- BALY 482.4M
- IPO Year
- AXGN N/A
- BALY N/A
- Fundamental
- Price
- AXGN $17.26
- BALY $10.60
- Analyst Decision
- AXGN Strong Buy
- BALY Hold
- Analyst Count
- AXGN 5
- BALY 7
- Target Price
- AXGN $26.00
- BALY $18.00
- AVG Volume (30 Days)
- AXGN 1.1M
- BALY 363.4K
- Earning Date
- AXGN 11-06-2025
- BALY 02-19-2025
- Dividend Yield
- AXGN N/A
- BALY N/A
- EPS Growth
- AXGN N/A
- BALY N/A
- EPS
- AXGN N/A
- BALY N/A
- Revenue
- AXGN $203,271,000.00
- BALY $2,481,783,000.00
- Revenue This Year
- AXGN $19.65
- BALY $3.06
- Revenue Next Year
- AXGN $15.84
- BALY N/A
- P/E Ratio
- AXGN N/A
- BALY N/A
- Revenue Growth
- AXGN 17.17
- BALY 2.80
- 52 Week Low
- AXGN $9.22
- BALY $9.74
- 52 Week High
- AXGN $21.00
- BALY $18.38
- Technical
- Relative Strength Index (RSI)
- AXGN 67.28
- BALY 63.00
- Support Level
- AXGN $16.11
- BALY $9.75
- Resistance Level
- AXGN $17.00
- BALY $11.10
- Average True Range (ATR)
- AXGN 0.58
- BALY 0.64
- MACD
- AXGN -0.00
- BALY 0.08
- Stochastic Oscillator
- AXGN 96.65
- BALY 78.35
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.